|
|
||||||||
Ann Thorac Surg 2007;83:209-214
© 2007 The Society of Thoracic Surgeons
a Department of General Thoracic Surgery, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan
b First Department of Pathology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan
Accepted for publication July 21, 2006.
* Address correspondence to Dr Sakao, Department of General Thoracic Surgery, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan (Email: sakao{at}med.juntendo.ac.jp).
BACKGROUND: We tried to clarify whether the histologic subtypes and the size of the solid component of an adenocarcinoma are more important predictive factors for invasiveness or prognosis than is total tumor size, even in lung adenocarcinomas that were 2 cm or smaller.
METHODS: Between 1996 and December 2005, after standard surgical treatment, 82 patients were diagnosed as having adenocarcinoma with a maximum diameter of 2 cm or less. The group comprised 37 females and 45 males, with ages ranging from 41 to 80 years (median, 64). The clinicopathologic records of the patients were examined with regard to age, sex, nodal status, tumor size (largest diameter of the total tumor as well as the largest diameter without the bronchioloalveolar carcinoma [BAC] component [solid component]), serum carcinoembryonic antigen level, and histologic type. These variables were analyzed as risk factors for vascular or lymphatic invasion, lymph node metastasis, and prognosis. Histologic subtype was classified into two groups: mixed BAC (mixed adenocarcinoma with BAC) and minimal or non-BAC (tumors with little or no BAC component).
RESULTS: Histologic subtype was a significant predictive factor both for invasiveness (vascular or lymph vessels) and lymph node metastasis, in both univariate and multivariate analysis. Tumor diameter was not a significant factor in either univariate or multivariate analysis (p = 0.28, 0.15, respectively). However, diameter excluding the BAC component was a significant factor for invasiveness in mixed BAC type (p = 0.035), whereas total diameter was not significant (p = 0.28). Finally, histologic subtype and lymph node metastasis were significant prognostic factors for survival in both univariate (p = 0.03, 0.05, respectively) and multivariate (p = 0.04, 0.05, respectively) analyses. The 5-year survival rate was 94.4% (94.1% for pN0) for the mixed BAC type and 71.4% (78.7% for pN0) for the minimal or non-BAC type (p = 0.009; p = 0.04 for pN0 nodes).
CONCLUSIONS: Small adenocarcinomas can be classified into two categories. The first category is a minimal or non-BAC adenocarcinoma that shows aggressive biological behavior. The second category is a mixed BAC, which demonstrates less invasive or aggressive biological behavior than the minimal or non-BAC type, with the degree of invasiveness being associated with the size of the non-BAC component.
Related Article
Ann. Thorac. Surg. 2007 83: 214-215.
This article has been cited by other articles:
![]() |
R. Maeda, J. Yoshida, G. Ishii, T. Hishida, M. Nishimura, and K. Nagai Risk Factors for Tumor Recurrence in Patients With Early-Stage (Stage I and II) Non-small Cell Lung Cancer: Patient Selection Criteria for Adjuvant Chemotherapy According to the Seventh Edition TNM Classification Chest, December 1, 2011; 140(6): 1494 - 1502. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Maeda, J. Yoshida, G. Ishii, T. Hishida, M. Nishimura, and K. Nagai Prognostic Impact of Histology on Early-Stage Non-small Cell Lung Cancer Chest, July 1, 2011; 140(1): 135 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Haruki, K. Shomori, T. Shiomi, Y. Taniguchi, H. Nakamura, and H. Ito The morphological diversity of small lung adenocarcinoma with mixed subtypes is associated with local invasiveness and prognosis Eur J Cardiothorac Surg, May 1, 2011; 39(5): 763 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ohtaki, J. Yoshida, G. Ishii, K. Aokage, T. Hishida, M. Nishimura, I. Takeyoshi, and K. Nagai Prognostic Significance of a Solid Component in Pulmonary Adenocarcinoma Ann. Thorac. Surg., April 1, 2011; 91(4): 1051 - 1057. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Meguid, C. M. Hooker, J. Harris, L. Xu, W. H. Westra, J. T. Sherwood, M. Sussman, S. M. Cattaneo II, J. Shin, S. Cox, et al. Long-term Survival Outcomes by Smoking Status in Surgical and Nonsurgical Patients With Non-small Cell Lung Cancer: Comparing Never Smokers and Current Smokers Chest, September 1, 2010; 138(3): 500 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Rodig, M. Mino-Kenudson, S. Dacic, B. Y. Yeap, A. Shaw, J. A. Barletta, H. Stubbs, K. Law, N. Lindeman, E. Mark, et al. Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population Clin. Cancer Res., August 15, 2009; 15(16): 5216 - 5223. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. JONES, K. L. IRION, and J. A. HOLEMANS A review of the imaging and clinical management of solitary pulmonary nodules Imaging, December 1, 2008; 20(4): 303 - 311. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pelosi and J. Rosai Invited commentary Ann. Thorac. Surg., January 1, 2007; 83(1): 214 - 215. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |